NORCROSS, Ga. — Omega Bio-tek, a leading nucleic acid purification kit manufacturer, announced today that the company received ISO 13485:2016 certification for Medical Devices- Quality Management Systems. This certification is an internationally recognized standard for a quality management system where an organization needs to demonstrate its ability to provide medical devices and related services that consistently meet […]

Active Motif Incorporated, a company with the vision of bringing epigenetics more deeply into precision medicine, announced that it has purchased Amaryllis Nucleics, a Bay Area-based start-up company focused on proprietary RNA Sequencing methods. Amaryllis Nucleics provides Active Motif with a streamlined, low-cost library preparation method to perform high-efficiency RNA sequencing using their intellectual property […]

70% of all U.S. states now using QIAcuity for ultra-sensitive wastewater detection of SARS-CoV-2 infections Over 35 QIAcuity systems shipped by end-2021 as part of a U.S. National Institutes of Health (NIH) supply contract for COVID-19 testing solutions QIAcuity digital PCR applications for wastewater-based epidemiology proving to be a vital early-warning surveillance tool for authorities […]

At Arab Health in Dubai, Group 42 Healthcare (G42 Healthcare) announced the certification of their Biogenix Labs with Oxford Nanopore technology, to carry out rapid SARS-CoV-2 sequencing as a service, providing the fastest, high accuracy sequencing with system flexibility. This certification will enable G42 to use Oxford Nanopore sequencing technology and the latest SARS-CoV-2 Sequencing Kit — […]

Customers in the Czech Republic, Hungary, Poland, Romania, and Slovakia can now extract higher yields of DNA and RNA from challenging biological samples in one hour with minimal hands-on time Pleasanton, Calif. –  Purigen Biosystems, Inc., a leading provider of next-generation technologies for extracting and purifying nucleic acids from biological samples, today announced a new […]

SAN FRANCISCO– Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Artisan Development Labs Inc. (DBA Artisan Bio), an immune cell engineering company developing next-generation cell therapies, today announced a collaboration to discover novel antibodies against five undisclosed targets, with an […]

Acquisition combines Aldevron’s leadership in GMP manufacturing with Nature Tech’s portfolio of proprietary technologies. Aldevron has acquired Nature Technology Corporation (NTC), a developer of innovative and proprietary plasmid constructs and manufacturing solutions that are used in the field of cell and gene therapy. NTC’s nucleic acid-based technologies include NanoplasmidTM, a proprietary vector construct that improves […]

The funding will drive international deployment of the company’s next generation genomic analysis platform to enable personalized medicine in cancers as well as rare and hereditary diseases. Montpellier – SeqOne Genomics, provider of next genomic analysis solutions for personalized medicine today announced a Series A funding round of €20M.  The round, led by Omnes, Merieux […]

TruSight™ Oncology 500 ctDNA panel to be used across a number of Asian countries to develop personalized cancer treatments for Nasopharyngeal Carcinoma SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) and the National Cancer Center Japan have announced an international joint research project that will use Illumina’s high-throughput DNA sequencing to analyse the blood-based genomic profile […]